Tony Chan Carusone

CTO

Alphawave Semi

Tony Chan Carusone was appointed Chief Technology Officer in January 2022.  Tony has been a professor of Electrical and Computer Engineering at the University of Toronto since 2001.  He has well over 100 publications, including 8 award-winning best papers, focused on integrated circuits for digital communication.  Tony has served as a Distinguished Lecturer for the IEEE Solid-State Circuits Society and on the Technical Program Committees of world’s leading circuits conferences.  He co-authored the classic textbooks “Analog Integrated Circuit Design” and “Microelectronic Circuits” and he is a Fellow of the IEEE.  Tony has also been a consultant to the semiconductor industry for over 20 years, working with both startups and some of the largest technology companies in the world.

Tony holds a B.A.Sc. in Engineering Science and a Ph.D. in Electrical Engineering from the University of Toronto.

Vladimir-Ducarmel Joseph

CDI Program Manager

Beth Israel Lahey Health Hospital & Medical Center

Vladimir-Ducarmel Joseph is one of the Clinical Documentation Integrity Program Directors at Beth Israel Lahey Health, where he spearheads a dedicated team of CDI professional experts to optimize clinical documentation best practices. With almost a decade in CDI leadership across diverse healthcare environments, Vladimir-Ducarmel holds a Master of Health Administration from George Washington University and his expertise encompasses physician leadership, team dynamics, CDI provider education, and program management. A fervent advocate for healthcare excellence, Vladimir-Ducarmel is adept at bridging the gap between clinical and administrative roles. He is proficient in various healthcare-oriented analytical and business tools, leveraging them to drive impactful CDI outcomes.

Kamleh Nicola

Partner

Marks & Clerk

Kamleh Nicola is a partner at Marks & Clerk and Co-Head of the firm’s Litigation practice in Canada. Her intellectual property litigation practice centers around patent, trademark, and copyright disputes. Though her client base is broad in scope, she specializes in Health and Life Sciences, working with domestic and multinational pharmaceutical, biopharma, and MedTech organizations. Kamleh is particularly knowledgeable on matters involving Canada’s patent linkage regimes, health regulatory and related compliance, and trade secrets.

 

Mike Gilbert

Partner

Marks & Clerk

Mike Gilbert is a partner at Marks & Clerk in London.  He is an Intellectual Property (IP) lawyer who advises clients in a wide variety of business sectors on issues including litigation and dispute resolution, IP strategy and risk limitation, due diligence projects and commercial and licensing transactions involving IP. His primary focus and expertise, however, lies in life sciences patent litigation where he is considered to be one of the UK’s leading practitioners. He has represented some of the world’s leading biopharmaceutical corporations in complex patent and technical disputes including Genentech, Roche, Chugai, Pfizer, Wyeth, AstraZeneca, MedImmune, Daiichi Sankyo, AbbVie, Amgen and Illumina to name but a few. Mike is well known for his strategic and creative vision and is consistently recommended in various legal directories including the World IP Review, Legal 500, Who's Who Legal and the IAM Patent 1000 guide, which describe him as “always at the top of the pile, especially for pharmaceutical matters”. Mike graduated from Cambridge University in 1989 with a degree in chemical engineering.